score,metric,date,value,year,sentence,number
0.7318832874298096,marketable securities,"december 31, 2020",$17.2 billion,2020,"as of december 31, 2020, cash, cash equivalents, and marketable securities held by foreign subsidiaries were $17.2 billion",17200000000.0
0.6525325179100037,marketable securities,2020,$257 million,2020,"as of december 31, 2019 and 2020, restricted cash, cash equivalents, and marketable securities were $321 million and $257 million",257000000.0
0.4233969748020172,marketable securities,"december 31, 2019",$55.0 billion,2019,"our principal sources of liquidity are cash flows generated from operations and our cash, cash equivalents, and marketable securities balances, which, at fair value, were $55.0 billion and $84.4 billion as of december 31, 2019 and 2020",55000000000.0
0.4233969748020172,marketable securities,2020,$84.4 billion,2020,"our principal sources of liquidity are cash flows generated from operations and our cash, cash equivalents, and marketable securities balances, which, at fair value, were $55.0 billion and $84.4 billion as of december 31, 2019 and 2020",84400000000.0
0.4026507437229156,marketable securities,2018,$145 million,2018,"other income (expense), net, consists primarily of valuations and adjustments of equity securities of $145 million, $231 million, and $833 million in 2018, 2019, and 2020, equity warrant valuation gains (losses) of $(131) million, $11 million, and $1.5 billion in 2018, 2019, and 2020, and foreign currency gains (losses) of $(206) million, $(20) million, and $35 million in 2018, 2019, and 2020.",145000000.0
0.4026507437229156,marketable securities,2019,$833 million,2019,"other income (expense), net, consists primarily of valuations and adjustments of equity securities of $145 million, $231 million, and $833 million in 2018, 2019, and 2020, equity warrant valuation gains (losses) of $(131) million, $11 million, and $1.5 billion in 2018, 2019, and 2020, and foreign currency gains (losses) of $(206) million, $(20) million, and $35 million in 2018, 2019, and 2020.",833000000.0
0.1423781365156173,r&d value,2020,$1.1 billion,2020,"during 2020, we acquired certain companies for an aggregate purchase price of $1.2 billion, net of cash acquired, of which $1.1 billion was capitalized to in-process research and development intangible assets (“ipr&d”).",1100000000.0
0.1154131442308425,marketable securities,2020,59.6) billion,2020,"cash provided by (used in) investing activities was $(24.3) billion and $(59.6) billion in 2019 and 2020, with the variability caused primarily by our decision to purchase or lease property and equipment, and purchases, maturities, and sales of marketable securities",59600000000.0
